Imaging

Cardiology in the Spotlight: Enterprise Imaging That Goes Beyond Radiology

The future of medical imaging is about connection. Today’s healthcare challenges demand platforms that unify radiology, cardiology, digital pathology, genomics, and beyond into a seamless enterprise ecosystem—moving past the era of standalone systems and isolated workflows. A complete enterprise imaging solution allows us to move closer to an improved multidisciplinary collaboration, and a more comprehensive patient overview. And this is where cardiology becomes a key component in a future proof and modern enterprise imaging strategy.

Proven excellence in radiology: Sectra, known for their leadership in radiology, have been named “Best in KLAS” for PACS 12 years in a row. But Sectra isn’t a one-trick pony. They’re building solutions that go far beyond radiology to unify diagnostics, helping healthcare teams break down silos and work together more effectively.

Innovation across specialties

  • Digital pathology leadership: Through partnership with Leica Biosystems, Sectra is the only IMS (Image Management System) with FDA clearance for primary diagnostics using DICOM in digital pathology. Unifying radiology and pathology data on a single platform enables true integrated diagnostics, enhancing cross-specialty collaboration and tumor board reviews.
  • Groundbreaking genomics integration: Last year marked another milestone with the launch of Sectra Genomics—an industry first within an enterprise imaging platform. This advancement allows healthcare providers to combine molecular and imaging insights, enabling precision medicine particularly in oncology care.

The next generation of cardiology imaging

As healthcare becomes increasingly integrated, Sectra continues to build on their foundation of success and to push boundaries by transforming cardiovascular workflows. Sectra Cardiology Imaging addresses the long-standing challenge of fragmented cardiac imaging by unifying ECGs, Echo, Cath, Cardiac NM, Vascular, and CT FFR within a single, intuitive interface.

Introducing Sectra Echo Viewer

Coming Spring 2025, the Sectra Echo Viewer will transform echocardiogram workflows with:

  • Lightning-fast loading and crystal-clear playback
  • Same full diagnostic quality in Sectra IDS7 and Sectra UniView
  • Comprehensive measurement tools with structured reporting export
  • Multi-protocol support for TTE, TEE, vascular, and pediatric studies
  • Cloud-optimized design for easy access, quick launching, and future scalability

Through continuous innovation in enterprise imaging, Sectra enables healthcare organizations to deliver more confident diagnoses and better patient outcomes. Connected diagnostics is no longer a future promise, but a present reality.

Welcome to the next generation of Sectra Cardiology Imaging, and to the transformation of your cardiovascular workflow.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Electrophysiology August 21, 2025

Conduction-System Pacing Succeeds at Treating AV Block August 21, 2025

Conduction-system pacing could be poised to reshape standard care for atrioventricular (AV) block patients after the randomized CSPACE trial demonstrated its significant benefits over traditional right ventricular septal pacing. Taking a closer look at CSP’s potential, the CSPACE trial enrolled 202 patients with AV block at two Australian hospitals, randomizing them to conduction-system pacing or […]

Cardiology Pharmaceuticals August 18, 2025

Rivaroxaban Monotherapy Could Be Better for CAD + AFib August 18, 2025

New analysis from the AFIRE trial suggests rivaroxaban monotherapy might be emerging as a preferred antithrombotic strategy for patients with AFib and stable coronary artery disease, especially in older age groups. The Post Hoc AFIRE Analysis examined 2,215 Japanese patients with AFib and stable CAD, stratifying them into four age groups (<70, 70-74, 75-79, and […]

Surgeries & Interventions August 14, 2025

TEER Could Save Lives in AFMR Patients August 14, 2025

Shedding light on a new treatment for an understudied condition, data published in EHJ suggests that transcatheter edge-to-edge repair (TEER) delivers significant survival advantages in patients with atrial functional mitral regurgitation (FMR). The new OCEAN-Mitral/REVEAL-AFMR Analysis compared 441 TEER-treated patients against 640 medically managed controls with moderate or severe atrial FMR, stating a solid case […]

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!